Use of Proceeds Covenant. No Borrower will request any Borrowing or Letter of Credit, and no Borrower shall use or permit its Subsidiaries and its or their respective directors, officers, employees and agents to use, the proceeds of any Borrowing or Letter of Credit (A) in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws, in any material respect, or (B) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Sanctioned Person, or in any Sanctioned Country, or (C) in any other manner that would result in the material violation of any Sanctions applicable to any party hereto.
Use of Proceeds Covenant. The Company hereby covenants and agrees that the Company shall use the proceeds of the sale of the Bonds to pay down outstanding lines of credit of the Company and the loan payable to the Corporation, and any additional proceeds shall be used to fund future capital investment by the Company.
Use of Proceeds Covenant. The Company hereby covenants and agrees that the Company will apply the proceeds of the sale of the Bonds to (i) repay short-term indebtedness, and (ii) finance the expansion of the Company’s headquarters building.
Use of Proceeds Covenant. The Company hereby covenants and agrees that the Company will apply the proceeds of the sale of the Bonds, together with other funds of the Company, to pay in full at maturity the indebtedness of the Company under the Series P Bonds.
Use of Proceeds Covenant. The first sentence of Section 10.7 of the Credit Agreement shall be amended to read in full as follows: "The proceeds of Borrowings will not be used for any purpose other than (a) the acquisition, exploration and development of Mineral Interests, and (b) general corporate purposes not prohibited by any other provision of this Agreement or other Loan Papers."
Use of Proceeds Covenant. The Company hereby covenants and agrees that the proceeds of the Acquisition Term Loans shall be used by the Company (a) to finance a portion of the Colomer Acquisition and for the payment of related transaction costs and expenses and to repay or acquire certain Indebtedness of the Acquired Business as contemplated by the Acquisition Agreement, (b) for the payment of transaction costs, fees and expenses incurred in connection with this Incremental Amendment and the transactions contemplated hereby and (c) with regard to any remaining amount, for general corporate purposes.
Use of Proceeds Covenant. Section 9.7 of the Credit Agreement shall be amended to read in full as follows:
Use of Proceeds Covenant. The Company will use the proceeds from the sale of the Shares for the general working capital needs of the Company and its subsidiaries.
Use of Proceeds Covenant. The Company shall use proceeds from the sale of the shares of A-2 Stock to fund development of its product pipeline, including the Company's AC-170 program and additional prescription programs and related overhead, related product development clinical stage programs, working capital and for general corporate purposes, in each case as determined by the Company's Board of Directors.
Use of Proceeds Covenant. The Company hereby covenants and agrees that the Company will apply the proceeds of the sale of the Bonds to prepay indebtedness of the Company under the Series O Bonds and the Series Q Bonds, and related prepayment costs or premiums.
